ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 11241 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 11241; 2) Community: the network communities that were significantly associated with the response to NSC 11241; 3) Molecule: the relationships between components within communities and NSC 11241; 4) MDR: the compounds that were significantly associated with the NSC 11241.

NSC Compound Enrichment Correlation
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0027236921521653 0.32546663
NSC 624172 Null 0.0027236921521653 0.32319315
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 0.0027236921521653 0.34534759
NSC 639981 Null 0.0027236921521653 0.48145846
NSC 645317 Sanguilutine pseudobase 0.0027236921521653 0.44390317
NSC 657822 (1R)-3,3-Dibromocamphor 0.0027236921521653 0.48082169
NSC 676769 Null 0.0027236921521653 0.58558621
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 0.0027236921521653 0.32769058
NSC 69852 1,4-Butanediamine, N,N'-bis(3-aminopropyl)-, tetrahydrochloride (8CI9CI) 0.0027236921521653 0.31311406
NSC 728040 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline 0.0027236921521653 0.31982079
Total:120  Current:14    [First] [Prev] [Next] [Last]